[Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents; D002415:Cats; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D008297:Male; D010647:Phenyl Ethers / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D010647:Phenyl Ethers; D011412:Propanolamines; D011433:Propranolol; D011217:Practolol
Struktur-Wirkungs-Beziehungen bei Phenoxyalkanolaminderivaten mit selektiver beta 1-Rezeptorenblockade